Transient Retrovirus-Based CRISPR/Cas9 All-In-One Particles for Efficient, Targeted Gene Knockout
Molecular Therapy - Nucleic Acids - United States
doi 10.1016/j.omtn.2018.09.006
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Elsevier BV